1IA
CNMD icon

1620 Investment Advisors’s CONMED CNMD Stock Holding History

1620 Investment Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-533
Closed -$25.1K – 659
2025
Q3 		$25.1K Sell
533
-4
-0.7% -$207 0.02% 365
2025
Q2 		$28K Hold
537
– – 0.02% 365
2025
Q1 		$32.4K Hold
537
– – 0.02% 340
2024
Q4 		$36.8K Sell
537
-23
-4% -$1.6K 0.03% 328
2024
Q3 		$40.3K Hold
560
– – 0.03% 330
2024
Q2 		$38.8K Buy
+560
New +$40.8K 0.03% 327

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

1620 Investment Advisors's CNMD Position: Q4 2025 in Review

1620 Investment Advisors sold out of CONMED (CNMD) in Q4 2025, closing a stake of 533 shares — an estimated $25.1K sold.

1620 Investment Advisors first reported a position in CNMD in Q2 2024 and held it in 6 quarters. The position peaked at $40.3K in Q3 2024. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • 1620 Investment Advisors reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • 1620 Investment Advisors sold 533 CONMED shares in Q4 2025, an estimated $25.1K.
  • 1620 Investment Advisors first reported a position in CONMED in Q2 2024 and held it in 6 quarters.
  • 1620 Investment Advisors's CONMED position peaked at $40.3K in Q3 2024.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on 1620 Investment Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.